Skip to content

Biocon Biologics introduces Hulio, a Humira biosimilar for rheumatoid arthritis, in US

The drug has been made available to patients in the United States after five years of experience in Europe and two years in Canada, the release said.

Read More

​ The drug has been made available to patients in the United States after five years of experience in Europe and two years in Canada, the release said. The drug has been made available to patients in the United States after five years of experience in Europe and two years in Canada, the release said.  Moneycontrol Latest News Read More  

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish